Apr 12, 2022 / 06:15PM GMT
Mike Matson - Needham & Company, LLC - Analyst
Good afternoon, everyone. Thanks for joining us again at the 21st Annual Needham Healthcare Conference. I'm Mike Matson, senior research analyst on the medtech and diagnostics team here.
Next up we have a presentation from TELA Bio. Presenting from TELA Bio is Antony Koblish, CEO; and Roberto Cuca, CFO. So I'll turn it over to Antony and Roberto, and they'll give a presentation. We should have some time for Q&A. (Conference Instructions) So with that, I will turn things over to Antony.
Antony Koblish - TELA Bio, Inc. - Co-founder, President & CEO
Thank you, Mike, and thank you everyone for joining our conference to learn about TELA Bio. Good afternoon. And just for the sake of completeness, Roberto is also our Chief Operating Officer as well as CFO. So with that, I'll start off by acknowledging our forward-looking statements, and then we'll continue on.
So TELA Bio, we are a soft tissue preservation and restoration company. We work in the area of reconstruction in the area of all
TELA Bio Inc at Needham Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot